Clinical Trial Update: European Long-acting Antipsychotics in Schizophrenia Trial-II

View source ↗

Summary

Clinical trial update for European long-acting antipsychotics in schizophrenia (Trial II) is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Rene Kahn | Conditions: Schizophrenia | Status: ENROLLING_BY_INVITATION